Just because a business does not make any money, does not mean that the stock will go down. For example, Sol-Gel Technologies (NASDAQ:SLGL) shareholders have done very well over the last year, with ...
Sol-Gel Technologies secures $16 million for clinical trials, advancing SGT-610 for Gorlin syndrome and extending cash runway to 2027. Sol-Gel Technologies, Ltd. has announced a product purchase ...
PreveCeutical said that Endosane has been, at no charge, granted the exclusive rights to the sol-gel technology for the sole purpose of analyzing and evaluating the technology and its scientific and ...
Vancouver, British Columbia--(Newsfile Corp. - January 9, 2023) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that it ...
Vancouver, British Columbia--(Newsfile Corp. - November 18, 2021) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical" or the "Company"), is pleased to announce that it ...
Patented technology for slow release of topical formulations. Potentially the first single-active benzoyl peroxide to be approved as prescription drug. Two late stage candidates. Funded sufficiently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results